Inhibition of migration and invasion of carcinoma cells by urokinase-derived antagonists of αvβ5 integrin activation-Reference-Cited by-同舟云学术

Inhibition of migration and invasion of carcinoma cells by urokinase-derived antagonists of αvβ5 integrin activation

Published:2009-01-15 Issue:2 Volume:124 Page:316-325
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Vocca Immacolata,Franco Paola,Alfano Daniela,Votta Giuseppina,Carriero Maria Vincenza,Estrada Yeriel,Caputi Mario,Netti Paolo A.,Ossowski Liliana,Stoppelli Maria Patrizia

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference39 articles.

1. The urokinase-type plasminogen activator system in cancer metastasis: a review;Andreasen;Int J Cancer,1997

2. Association of the circulating levels of the urokinase system of plasminogen activation with the presence of prostate cancer and invasion, progression, and metastasis;Shariat;J Clin Oncol,2007

3. The urokinase plasminogen activator receptor as a gene therapy target for cancer;Pillay;Trends Biotechnol,2007

4. Structure of human urokinase plasminogen activator in complex with its receptor;Huai;Science,2006

5. Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide;Llinas;EMBO J,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An engineered ultrahigh affinity bi‐paratopic uPAR targeting agent confers enhanced tumor targeting;Biotechnology and Bioengineering;2024-07-04

2. αV-Integrin-Dependent Inhibition of Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry by the uPAcyclin Decapeptide;Cancers;2023-09-28

3. Breast Tumor Cell Invasion and Pro-Invasive Activity of Cancer-Associated Fibroblasts Co-Targeted by Novel Urokinase-Derived Decapeptides;Cancers;2020-08-24

4. Paracrine recruitment and activation of fibroblasts by c‐Myc expressing breast epithelial cells through the IGFs/IGF‐1R axis;International Journal of Cancer;2019-08-23

5. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells;Journal of Controlled Release;2017-09